发明名称 SPHINGOSINE DERIVATIVES
摘要 Sphingosine derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof, wherein R<1> and R<2> are each hydrogen or the like; Z is NR<7> (wherein R<7> is hydrogen or the like); Y is oxygen or NR<8> (wherein R<8> is hydrogen or the like); W is oxygen or sulfur; and k is an integer of 1 to 20. The derivatives and the salts are useful as preventive or therapeutic drugs for cerebrovascular disorders such as cerebral hemorrhage and cerebral infarction; head injuries; senile dementia; degenerative diseases of cranial nerve such as Alzheimer disease and Parkinson disease; diabetes; obesity; arteriosclerosis; inflammatory diseases; immunologic diseases; cancers; kidney diseases; and heart diseases.
申请公布号 WO0138295(A1) 申请公布日期 2001.05.31
申请号 WO2000JP08229 申请日期 2000.11.22
申请人 TAISHO PHARMACEUTICAL CO.,LTD.;SAGAMI CHEMICAL RESEARCH CENTER;KOBORI, TAKEO;SUGIMOTO, KIKUO;GODA, KENICHI;TAGUCHI, MINORU 发明人 KOBORI, TAKEO;SUGIMOTO, KIKUO;GODA, KENICHI;TAGUCHI, MINORU
分类号 A61P3/04;A61P3/10;A61P9/10;A61P13/12;A61P25/16;A61P25/28;A61P29/00;A61P35/00;C07C271/20;C07C311/53;C07C323/43;C07D233/61;C07D233/64;C07D277/46;(IPC1-7):C07C271/08;A61K31/17;A61K31/27;A61K31/41;A61K31/416;A61K31/426;A61K31/433;A61K31/44;A61K31/440;A61K31/496;A61K31/537;C07C271/12;C07C271/16;C07C271/22;C07C271/28;C07C275/20;C07C275/42;C07D213/53;C07D213/75;C07D231/56;C07D241/20;C07D257/06;C07D285/12;C07D295/12 主分类号 A61P3/04
代理机构 代理人
主权项
地址